American Tegumentary Leishmaniasis: Fluconazole therapy

Abstract

The treatment of American Tegumentary Leishmaniasis (ATL) constitutes a challenge for public health. This is due to a series of factors, amongst them: difficult access to the forest regions, the exclusively parenteral route of administration of the first-choice drug and the need of monitoring adverse effects. This study describes three cases of ATL treated with Fluconazole. This drug was used for the following reasons: existence of some contraindication, adverse effects and only partial or inexistent response to Antimony treatment. Complete reepitheliazation of skin wounds was verified in all three cases. However, further and more extensive clinical studies including control groups will be necessary for confirming the results obtained in the present study.